Photo of Evan Lim

Evan Lim is an associate in the Intellectual Property Practice Group in the firm's Silicon Valley office.

This case addresses the legal standard for inherent anticipation.

Background

The ’127 patent is directed to an invention that provides stable nucleic acid-lipid particles (“SNALP”) that have non-lamellar structure and

Continue Reading Arbutus Biopharma Corporation, FKA Protiva Biotherapeutics, Inc., v. Modernatx, Inc., FKA Moderna Therapeutics, Inc. No. 2020-1183 (Fed. Cir. April 11, 2023)

We are excited to share Sheppard Mullin’s inaugural quarterly report on key Federal Circuit decisions. The Spring 2023 Quarterly Report provides summaries of most key patent law-related decisions from January 1, 2023 to March 31, 2023.

Continue Reading 2023 Federal Circuit Case Summaries